DrugPatentWatch Database Preview
Drugs in MeSH Category Antineoplastic Agents
Email this page to a colleague
See Plans and Pricing| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Novartis | AFINITOR | everolimus | TABLET;ORAL | 022334-003 | Jul 9, 2010 | AB | RX | Yes | No | Start Trial | Start Trial | Start Trial | |||
| Valeant Intl | RETIN-A-MICRO | tretinoin | GEL;TOPICAL | 020475-003 | Jan 28, 2014 | RX | Yes | Yes | Start Trial | Start Trial | Start Trial | ||||
| Bristol Myers Squibb | SPRYCEL | dasatinib | TABLET;ORAL | 021986-004 | May 30, 2008 | RX | Yes | Yes | Start Trial | Start Trial | Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
